布地奈德联合阿奇霉素治疗小儿支原体肺炎的疗效

Budesonide Combined With Azithromycin in the Treatment of Children With Mycoplasma Pneumonia

目的了解布地奈德雾化吸入联合阿奇霉素治疗小儿支原体肺炎的临床疗效。方法以随机法将本院2014年1月—2016年12月收治的160例小儿支原体肺炎患者分成两组:给予阿奇霉素治疗的80例为对照组,予以布地奈德+阿奇霉素治疗的80例为治疗组,对比两组患者的治疗效果。结果予以不同药物后,治疗组患者的治疗有效率为95.00%,高于对照组的77.50%,组间数据对比,差异具有统计学意义(P<0.05);对照组治疗后16例发生不良反应症状,而治疗组仅4例,组间数据对比,差异具有统计学意义(P<0.05)。结论临床治疗小儿支原体肺炎,联用布地奈德雾化吸入与阿奇霉素展开治疗,可明显防治不良反应,提高治疗效果。

Objective To investigate the clinical efficacy of budesonide inhalation combined with azithromycin in the treatment of mycoplasma pneumonia in children.Methods From January 2014 to December 2016,160 cases of mycoplasma pneumoniae pneumonia were randomly divided into 2 groups:80 cases treated with azithromycin and 80 cases treated with budesonide and azithromycin group,compared with two groups of treatment.Results After giving different drugs,the effective rate of the treatment group was 95.00%,which was higher than 77.50%of the control group,and the difference between the two groups was statistically significant(P<0.05).In the control group,16 cases had adverse reaction symptoms,but only 4 cases in the treatment group,the difference between the groups was statistically significant(P<0.05).Conclusion The clinical treatment of children with mycoplasma pneumonia,combined with budesonide inhalation and azithromycin inhalation therapy can significantly prevent and treat adverse reactions and improve the therapeutic effect.